<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>The Trypanosoma cruzi Protease Cruzain Mediates <br /> Immune Evasion <br /> Patricia S. Doyle*, Yuan M. Zhou, Ivy Hsieh, Doron C. Greenbaum&#194;&#164;, James H. McKerrow, Juan C. Engel <br /> Tropical Disease Research <span id='am-2' about='Thesaurus:Unit' typeof='owl:Thing'>Unit</span> Sandler Center Drug Discovery, Department Pathology, University California, San Francisco, California, United States of <br /> America <br />  <br />  <br />  <br />      <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />      Trypanosoma cruzi causative agent Chagas&#226;&#8364;&#8482; disease. Novel chemotherapy drug K11777 targets major <br />      cysteine protease cruzain disrupts amastigote intracellular development. Nevertheless, biological role the <br />      protease infection pathogenesis remains unclear cruzain gene <span id='am-242' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-243' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-244' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-245' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-246' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-248' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-249' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-250' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-251' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-252' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-253' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-254' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-255' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-256' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-257' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-258' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-259' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-260' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-261' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-263' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-264' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-265' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-266' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-267' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-268' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-269' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-270' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-271' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-272' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-273' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-274' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-275' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-276' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-277' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-278' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-279' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-280' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-281' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-282' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-283' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-284' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-285' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-286' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-287' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-288' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-289' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-290' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-291' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-292' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-293' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-294' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-295' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-296' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-297' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-298' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-299' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-300' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-301' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-302' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-303' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-304' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-305' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-306' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-307' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-308' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-309' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-310' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-311' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-312' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-313' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-314' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-315' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-316' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-317' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-318' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-319' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span>knockout</span> failed genetic redundancy. A role <br />      T. cruzi cysteine protease cruzain immune evasion elucidated comparative study parental wild type- <br />      cruzain-deficient parasites. Wild type T. cruzi did activate host macrophages early infection (,60 min) and <br />      increase ,P ikB detected. The signaling factor NF-kB P65 colocalized cruzain cell surface of <br />      intracellular wild type parasites, proteolytically cleaved. No significant IL-12 expression occurred macrophages <br />      infected wild type T. cruzi treated LPS BFA, confirming impairment macrophage activation pathways. <br />      In contrast, cruzain-deficient parasites induced macrophage activation, detectable ikB phosphorylation, nuclear NF-kB <br />      P65 localization. These parasites unable develop intracellularly survive macrophages. IL 12 expression <br />      levels macrophages infected cruzain-deficient T. cruzi comparable LPS activated controls. Thus cruzain <br />      hinders macrophage activation early (,60 min) stages infection, interruption NF-kB P65 mediated <br />      signaling pathway. These early events allow T. cruzi <span id='am-8' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-9' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-15' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-25' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-27' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-33' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-37' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-46' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-55' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-63' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-66' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-67' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-74' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-83' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span>survival</span> replication, lead spread infection acute <br />      Chagas&#226;&#8364;&#8482; disease. <br />  <br />   Citation: Doyle PS, Zhou YM, Hsieh I, Greenbaum DC, McKerrow JH, et al. (2011) The Trypanosoma cruzi Protease Cruzain Mediates Immune Evasion. PLoS <br />   Pathog 7(9): e1002139. doi:10.1371/journal.ppat.1002139 <br />   Editor: Ingrid Mu&#194;&#168;ller, Imperial College London, United Kingdom <br />   Received November 29, 2010; Accepted May 11, 2011; Published September 1, 2011 <br />   Copyright: &#195;&#376; 2011 Doyle et al. This open-access article distributed terms Creative Commons Attribution License, permits <br />   unrestricted use, distribution, reproduction medium, provided original author source credited. <br />   Funding: NIAID TDRU AI 35707 Sandler Foundation supported work. The funders role study design, data collection analysis, decision <br />   publish, preparation manuscript. <br />   Competing Interests: The authors declared competing interests exist. <br />   * E-mail: Patricia.Doyle-Engel@ucsf.edu <br />   &#194;&#164; Current address: Department Pharmacology, University Pennsylvania School Medicine, Philadelphia, Pennsylvania, United States America. <br />  <br />  <br />  <br />  <br /> Introduction                                                                         cruzain involvement trypomastigote infection the <br />                                                                                      proteolytic release kinin host cells surfaces activation <br />    Trypanosoma cruzi parasitic agent Chagas&#226;&#8364;&#8482; disease                  bradykinin receptors [12&#226;&#8364;&#8220;14]. More recent reports suggested <br /> affects approximately 12 million people Latin America                     cruzain mediates anti-apoptotic mechanisms T. cruzi- <br /> (WHO). Current chemotherapy nifurtimox benznidazole                         infected myocardiocytes vitro [15]. The biological role cruzain <br /> is unsatisfactory severe effects require medical                    intracellular amastigote stage T. cruzi Chagas&#226;&#8364;&#8482; <br /> supervision [1&#226;&#8364;&#8220;3]. T. cruzi infection classically transmitted               disease pathogenesis remains largely unknown. <br /> insect vector, reduviid bug [4]. Parasites disseminate                  Assessments role cruzain T. cruzi pathogenicity have <br /> insect bite site and, common clinical course Chagas&#226;&#8364;&#8482;                  hampered genetic redundancy failure gene <br /> disease, infect cardiac myocytes leading acute myocarditis                     deletion attempts [9,12,16,17]. Successful knockout cruzain <br /> chronic infection relentless cardiac failure. Fulminant disease                 gene cluster achieved date leading speculation <br /> is commonly seen HIV infection immunosuppression. In                         deletion cruzain coding genes lethal. <br /> patients immunodeficieny, parasites                        Chemical knockout cysteine protease inhibitors also <br /> organs, highly fatal meningoencephalitis ensues. These                   lethal T. cruzi [18]. Although role auto-proteolysis in <br /> observations led hypothesize T. cruzi successfully evades                 cruzain activation confirmed, studies did allow <br /> the host immune response, fact utilize unresponsive                       elucidation biological role protease human disease. <br /> macrophages means egress insect bite site prior                  Duschak et al. [19,20] observed lower cruzain activity protease <br /> dissemination cell types [5]. While specific                            sequence alterations attenuated strains compared their <br /> mechanisms immune evasion T. cruzi remain largely                              virulent parental T. cruzi, authors infectivity is <br /> unknown, reports suggested major protease                      dependent cruzain expression activity [21]. An <br /> of T. cruzi, cruzain, (a.k.a. cruzipain, GP57/51) key factor [6,7].             alternative approach study biological role vital gene <br />    Cruzain plays biological role cell remodeling                         product examine <span id='am-164' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-165' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-167' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-173' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-177' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-178' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-181' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-182' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-183' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-186' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-194' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-195' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-196' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-198' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-199' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-200' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-204' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-206' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-209' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-217' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-220' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-221' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-228' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-231' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-238' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-239' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-240' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-241' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span>phenotype</span> protease-deficient <br /> transformation insect epimastigote stage T. cruzi                       organisms. We generated protease deficient T. cruzi retained <br /> infectious metacyclic [8&#226;&#8364;&#8220;11]. Scharfstein collaborators                    1% cruzain activity wild type parental clone <br />  <br />  <br />        PLoS Pathogens | www.plospathogens.org                                    1                       September 2011 | Volume 7 | Issue 9 | e1002139 <br />                                                                                                       T. cruzi Protease Mediates Immune Evasion <br />  <br />  <br />  <br />   Author Summary                                                           Ethics statement <br />                                                                               This study carried strict accordance Guide <br />   Trypanosoma cruzi (T. cruzi) unicellular parasite            Care Use Laboratory Animals National <br />   causes Chagas&#226;&#8364;&#8482; disease, devastating health burden                      Institutes Health. The protocol approved the <br />   Latin America affecting developed                    Institutional Animal Care Use Committee University <br />   countries. Macrophages cells                   California, San Francisco (AN079928-02A). <br />   infected T. cruzi disseminate infection other <br />   tissues. The parasite preferentially infects and <br />   multiplies heart muscle cells causing severe heart                Protease labeling <br />   disease death. The new drug K11777 targets                      WT cruzain-deficient epimastigotes washed three <br />   vital parasite enzyme, protease cruzain. Consequently,               times PBS, counted Coulter Counter Multisizer 3 <br />   important understand enzyme doing                   (Beckman) taken equal numbers parasites/ml, lysed by <br />   infection. <span id='am-7' about='protege:TO' typeof='owl:Thing'>To</span> elucidate role protease,              5 cycles freeze-thawing, centrifuged 14,000 xg 1 h 4uC <br />   compared infection macrophages parental wild                     [22], frozen 270uC used. Fractions (105 epimasti- <br />   type parasites protease deficient T. cruzi. We              gotes/lane) reacted iodinated inhibitor DCG04 <br />   report role parasitic protease immune evasion.              [27,28] electrophoresed. Resolved molecular species were <br />   The protease prevents macrophage activation allow-                  isolated analyzed nano LC/MS, CID spectra, and/or <br />   ing T. cruzi survival replication, favoring                  fractionation MALDI-TOF Protein Facility, UCSF. <br />   spread infection.                                                     Protein fragments (9-17 aa long) analyzed NCBI blast. <br />  <br />  <br /> [22]. We report cruzain deficient T. cruzi rapidly activate       Immunoelectron microscopy (IEM) <br /> host macrophages NF-kB P65 unable survive                      BESM cells infected intracellular amastigotes WT or <br /> intracellularly macrophages. In contrast, infection wild       cruzain-deficient T. cruzi processed IEM specific <br /> type parasites appears induce cruzain-mediated proteolysis           anti-cruzain polyclonal antibody previously described [24]. <br /> NF-kB P65 leading unresponsiveness host macrophage               Briefly, T. cruzi-infected BESM cells collected centrifuga- <br /> during early (,60 minutes) infection. This immune evasion                  tion, washed twice PBS fixed 2 hours 4uC 2% <br /> mechanism critical T. cruzi survival early               paraformaldehyde-0.05% glutaraldehyde 0.1 M phosphate <br /> natural infection low number trypmastigotes.                     buffer, pH 7.4. Cells cryoprotected, frozen, sectioned, <br />                                                                            immunolabeled sequentially rabbit polyclonal anti- <br />                                                                            cruzain Ab goat anti-rabbit IgG-10 nm gold-labeled Ab <br /> Materials Methods <br />                                                                            (dilutions 1:250 1:500, respectively). Thin sections were <br /> Parasites cells                                                        observed Tecnai 10 (FEI Co.) electron microscope. Gold- <br />    Wild type CA-I/72 T. cruzi isolated Argentinean             labeled cruzain localizing amastigote cell surface was <br /> chronic chagasic patient cloned [23]. Cruzain-deficient,           quantified micrographs intracellular parasites three <br /> cysteine protease inhibitor (K11777)-resistant (CA-I/KR; KR) T.            independent experiments (n = 55 wild type amastigotes; n = 55 <br /> cruzi derived parental CA-I/72 parasites [22]. The               cruzain-deficient amastigotes). The cell perimeter sectioned <br /> cysteine protease inhibitor K11777 (K777, N-Methyl-Pip-F-hF-               intracellular amastigotes measured Openlab software <br /> VSW) kindly provided J. Palmer, Celera, CA [18,24].                 (Improvision), cruzain density expressed number of <br /> Epimastigotes maintained 26uC Brain-heart tryptose              gold labeled cruzain particles/mm parasitic cell membrane. <br /> (BHT) medium [25] 10% heat inactivated fetal calf serum               Results statistically analyzed (t test). <br /> (FCS), addition 20-fold lethal dose (200 mM) of <br /> K11777 phenotypic cruzain-deficient CA-I/KR.                           Western blots (WB) <br />    Bovine embryo skeletal muscle cells (BESM) cells kind               J774 macrophages seeded 12 tissue culture plates <br /> gift J. A. Dvorak, NIH. Mammalian stages wild type (WT)              24 h prior infection WT cruzain-deficient T. cruzi as <br /> CA-I/72 maintained BESM cells RPMI-1640                       appropriate. Infection performed low ratio 0.5 <br /> medium 5% heat inactivated horse serum (HS) 37uC                    parasites/macrophage. Some infected cultures treated with <br /> [26]. Intracellular cruzain-deficient CA-I/KR T. cruzi                cysteine protease inhibitor. Controls consisted J774 macrophage <br /> maintained serially BESM addition              cultures uninfected, treated purified LPS (150 ng/ <br /> 5% heat inactivated FCS, 5% heat inactivated horse serum,              ml LPS, Sigma) [29], treated K11777. Samples were <br /> 10 mM K11777. Long-term culture higher concentrations            collected 1 min, 30 min, 60 min, 150 min, 48 h <br /> inhibitor toxic BESM cells. For experiments,              post-infection. Monolayers washed twice cold PBS, <br /> mammalian stages cruzain-deficient CAI/KR                     solubilized 1 ml cold PBS with1% Triton X-100, scraped, <br /> cultured 4 passages (2 months) absence inhibitor.            aliquoted, immediately snap-frozen, stored 270uC until <br /> The approximate duration intracellular cycle wild type           used. Samples centrifuged 14,000 xg 30 min 4uC <br /> CA-I/72 (4.5 days) [23] CA-I/KR (18 days) estimated             supernatants taken identical protein concentration. <br /> infected BESM cells contrast phase microscopy                    Samples (1 mg protein/lane) heated 70uC 5 min and <br /> fluorescence microscopy propidium iodine stained slides.                resolved Nupage electrophoresis (10% BisTris gels 200 V, <br /> Cruzain-deficient parasites unable survive develop             Mops Buffer) (Novex, Invitrogen) prior transferring PVDF <br /> within macrophages.                                                        membranes (35 V 2 h). Blots blocked overnight 1% <br />    J774 mouse macrophages UCSF cell culture                  BSA (Sigma). Samples blotted rabbit anti&#226;&#8364;&#8220;NF-kB P65 <br /> facility. J774 cells cultured experiments        Ab, rabbit anti- ikB Ab, mouse anti-phosphorylated (,P) ikB Ab <br /> irradiated (1000 Rad) 24 h prior use arrest cell division.           (Santa Cruz Biotech, CA) anti actin Ab (Cal Biochem). All <br /> Normal peritoneal macrophages collected C3H mice                 methods according manufacturer&#226;&#8364;&#8482;s instructions (Santa <br /> (The Jackson Lab).                                                         Cruz Biotech, CA). Additional controls similarly infected <br />  <br />  <br />       PLoS Pathogens | www.plospathogens.org                           2                    September 2011 | Volume 7 | Issue 9 | e1002139 <br />                                                                                                      T. cruzi Protease Mediates Immune Evasion <br />  <br />  <br /> with Leishmania mexicana, kind gift J. Mottram (University        stained macrosialin (mouse CD68 homolog) specific Ab <br /> Glasgow, UK), 48 hours. Results confirmed duplicate           (Serotec) (Dil 1/200) followed CY2 affinity-pure donkey anti- <br /> experiments according methods described Ma                      rat IgG (Jackson Immuno-Research lab) secondary Ab PI <br /> colleagues [30&#226;&#8364;&#8220;32]. Briefly, 56106 cells point (1, 10, 30,        (Molecular Probes). <br /> 60 min) infected T. cruzi trypomastigotes (ratio <br /> 0.5 parasites/cell). Non-infected macrophages untreated            Proteolysis NF-kB P65 <br /> (MW) treated LPS, and/or K11777 indicated (10, 20, 40             Human recombinant NF-kB P65 (rNF-kB P65) (Active Motif, <br /> and 60 min) used controls. Macrophages washed           Japan) expressed E. coli full-<span id='am-6' about='xsp:length' typeof='owl:Thing'>length</span> cDNA clone 14 <br /> twice PBS, scraped, transferred eppendorf tubes,              aa deletion C-term. One ml rNF-kB P65 diluted to <br /> centrifuged prior lysis NP40 lysis buffer (0.1% NP40,             150 nM 10 ml 1x buffer (with 5 ml 1M DTT/ml 5 mM <br /> 1 mM Na vanadate 5 mM Na fluoride250 mM HEPES).                       DTT) reacted recombinant cruzain 150 nM (1/ <br /> Nuclei pelleted centrifugation (20 min 14,000 xg,         1) serial dilutions (1/10 1/1000) 100 mM Na Acetate <br /> 4uC) discarded, supernatants boiled Laemli            Buffer pH 5.5 2 h 37uC. Human rNF-kB P65 also <br /> buffer 10 min immediately prior SDS-PAGE/WB (Cell                  reacted sonicates 2.56105 wild type CA-I/72 cruzain <br /> Signalling Technology) [30,31]. Membranes developed                  deficient CA-I/KR parasites above. Samples resolved <br /> sequentially anti ,PikB Ab (Cell Signalling), anti-ikB Ab            WB anti- NF-kBP65 Ab. <br /> (Cell Signalling), anti-actin Ab (Southern Biotech) [30]. <br />                                                                           T. cruzi vitro assay <br /> Confocal microscopy                                                          To better understand effect macrophage activation on <br />    Duplicates samples described WB appropriate           parasite intracellular development, macrophages infected <br /> controls simultaneously seeded 12 tissue culture           WT T. cruzi (ratio 0.5 trypomastigotes/cell) 1 h 37uC. <br /> plates containing sterile round cover glasses. At 1 min, 30 min,          Cultures included untreated controls, macrophages treated <br /> 60 min, 150 min post-infection, cells washed, fixed         150 nM purified LPS [29] follows: LPS added 1 h <br /> fresh 4% paraformaldehyde PBS, rinsed PBS, treated             prior T. cruzi infection, concomitantly infection, 1 h <br /> 0.1% Triton X-100 PBS 5 min, rinsed, processed             infection. Cultures treated LPS 48 h. <br /> confocal microscopy anti -mouse NF-kB P65Ab (Dil 1/100;              Duplicate cultures fixed 4% paraformaldehyde 1 h <br /> Santa Cruz Biotech, CA) followed Alexa 488 labeled secondary           (to), 24 h, 48 h post-infection. Cells stained PI and <br /> Ab propidium iodine (Molecular Probes). Results 3&#226;&#8364;&#8220;           mean number intracellular parasites/cell estimated in <br /> 7 independent experiments (n = 2&#226;&#8364;&#8220;3 slides treatment).                 200 cells slide (n = 3 slides/treatment) independent <br /> Confocal images acquired Leica Laser Confocal                 experiments [26]. Results analyzed statistically (t test). <br /> microscope TCS-NP, using Leica software identical param- <br /> eters samples, namely, 100X objective numerical          Cruzain L-arginase assays <br /> aperture 1.4 102461024 format, pinhole 0.7 airy,            Cruzain activity determined extracts WT cruzain- <br /> a Z section 0.2 mm.                                                    deficient CA-I/KR epimastigotes previously described [22]. For <br />    For colocalization studies cruzain NF-kB P65, macro-            L-arginase determinations [7,34], J774 uninfected controls and <br /> phages infected 30 min WT T. cruzi treated            macrophages infected WT cruzain-deficient trypomasti- <br /> with K11777, similarly infected cruzain-deficient T. cruzi        gotes used. Cells collected 48 h post-infection and <br /> and treated K11777, non-infected controls            samples fixed 4% paraformaldehyde counting Coulter <br /> fixed stained sequentially rabbit anti-NF-kB P65 Ab (Dil         Counter Multisizer 3 (Beckman). Aliquots corresponding to <br /> 1/100; Santa Cruz Biotech) Alexa 488-labeled secondary Ab,            105cells/50 ml prepared duplicate L-arginase assays <br /> followed rabbit polyclonal anti-cruzain antibody (Dil 1/100)           described Stempin et al. [7] Briefly, cells lysed 0.1% <br /> [24] previously labeled Alexa 594 according manufactur-           Triton X-100 buffer protease inhibitors, centrifuged at <br /> er&#226;&#8364;&#8482;s instructions (Molecular Probes).                                     14,000 xg 30 min 4uC, supernatants stored 270uC. <br />    For confocal studies IL12 expression, macrophages treated        L-arginase activity supernatants determined described <br /> not K11777 infected WT cruzain-deficient T.             [7,34]. Urea (mg/ml) measured 540 nm. Results three <br /> cruzi 1 h (ratio 0.5 trypomastigotes/macrophage) followed          independent experiments (n = 3 sample) analyzed <br /> overnight incubation fresh RPMI medium 37uC. Cultures             statistically Prism 4 software. <br /> were exposed 150 ng/ml purified LPS 2 h (Sigma), <br /> followed 5 mg/ml BFA (Molecular Probes) 1 h 37uC.               Results <br /> Appropriate controls included independent exper- <br /> iments (n = 2 sample). Slides fixed above,           Cruzain-deficient T. cruzi <br /> simultaneously stained anti-IL12 antibody (1/100) (R&amp;D                  The cysteine protease inhibitor K11777 cidal WT T. cruzi. <br /> Systems) [33] 1 h followed secondary Cy2-labeled                   By exposing CA-I/72 T. cruzi gradual step-wise micromolar <br /> secondary Ab (dil 1/1000) (Biomed) propidium iodine (PI)              increases K11777 concentration period 2 years, we <br /> (Dil 1/5000) (Molecular Probes). Coverslips mounted             generated K11777-resistant cruzain-deficient T. cruzi that <br /> Vecta-Shield (Vector Lab). All slides observed                   retains negligible (,1%) protease activity detected a <br /> documented day Leica microscope, model                   fluorescent protease substrate [22]. Both parental WT and <br /> TCS-NP, using Leica software identical confocal parameters            cruzain-deficient parasites clonal populations [22]. Cruzain- <br /> as described above. The microscopist analyzed slides blindly.         deficient T. cruzi remained resistant K11777 14 years <br /> Fluorescence analyzed quantitatively Openlab                passage animals. The mechanism drug <br /> software (Improvision). Fluorescence intensity recorded            resistance described epimastigotes to <br /> random (n = 12 sample) statistically analyzed (t test).           secretion inactive, unprocessed cruzain [22]. The IC50 CA- <br />    For additional studies, macrophages infected WT             I/72 epimastigotes 3&#226;&#8364;&#8220;5 mM K11777 cruzain-deficient <br /> and cruzain-deficient CA-I/KR, uninfected controls               epimastigotes routinely maintained 20-fold lethal dose of <br />  <br />  <br />       PLoS Pathogens | www.plospathogens.org                          3                    September 2011 | Volume 7 | Issue 9 | e1002139 <br />                                                                                                         T. cruzi Protease Mediates Immune Evasion <br />  <br />  <br /> K11777 (200 mM). IC50 values intracellular wild type                Similar results obtained methods Abs the <br /> cruzain-deficient amastigotes 0.8&#226;&#8364;&#8220;1 mM 12 mM K11777,                different vendors. WB analyses anti-NF-kB P65 Ab <br /> respectively.                                                               (Figure 3A) showed expression macrophages infected WT <br />    Differing parental CA-I/72 T. cruzi lethal              T. cruzi 1 min 30 min post-infection (lanes 1, 4) similar <br /> doses $103 trypomastigotes, cruzain-deficient parasites              uninfected controls (lane 3), lower (lane 8) 60 min post- <br /> unable establish infection normal mice doses 106           infection. Phosphorylation ikB indicative cell activation <br /> trypomastigotes lethal severely immunodeficient           [40,45]. Samples WB heated 70uC 5 min <br /> Rag 1 2/2 mouse model Chagas&#226;&#8364;&#8482; disease (Doyle, unpublished                (Santa Cruz Biotech. methods) boiled 10 minutes <br /> data). These results independently submitted                    immediately prior SDS-PAGE dissociate complexes [30&#226;&#8364;&#8220; <br /> publication.                                                                32]. Samples blotted specific anti ,PikB Abs different <br />                                                                             commercial sources using different protocols confirmed <br /> An active site affinity tag identifies processed active                     negligible ,P ikB indicative unresponsiveness macrophages <br /> proteases wild type cruzain deficient T. cruzi                       infected WT T. cruzi 60 min uninfected controls <br />    To identify compare proteases WT cruzain-deficient            (Figure 3B). In contrast, ,P ikB indicative activation was <br /> T. cruzi, used functional proteomic method developed                confirmed macrophages infected cruzain-deficient T. cruzi <br /> profile protease targets crude cellular extracts [27,28]. The            early 1 min post-infection. Additional macrophage controls <br /> iodinated probe DCG04, allowed specific identification               infected cruzain-deficient T. cruzi cultured 2 months <br /> mature, active cruzain parental WT epimastigotes                    K11777 showed intermediate results parasites <br /> following SDS-PAGE (Figure 1). Cruzain-deficient parasites                  regained partial cruzain activity, investigated <br /> expressed unprocessed inactive cruzain prodomain                   [22]. Additional controls uninfected macrophages <br /> attached previously shown WB [22] active mature                treated LPS and/or K11777 (K77) (Figure 3D). In L. <br /> protease. The identity cruzain confirmed MS/MALDI                 mexicana infected controls [32], NF-kB P65 degradation still <br /> and NCBI blast.                                                             observed 48 h post-infection (data shown). <br />    To confirm decreased cruzain expression intracel- <br /> lular pathogenic amastigote stage performed comparative,                 NF-kB translocated nucleus in <br /> quantitative IEM. A statistically significant (p,0.1) three-fold            macrophages infected cruzain-deficient parasites <br /> decrease expression membrane bound cruzain confirmed                 To investigate macrophage responses WT versus <br /> for intracellular cruzain-deficient amastigotes compared WT           cruzain deficient T. cruzi-infection, performed confocal studies. <br /> controls (Figure 2).                                                        NF-kB P65 localization cytoplasmic macrophage controls <br />                                                                             (Figure 4E). NF-kB P65 localization cytoplasmic in <br /> Transcription factor NF-kB P65 activated                         macrophages infected WT T. cruzi 1, 30, 60 min post- <br /> macrophages infected cruzain-deficient parasites                       infection confirming unresponsiveness T. cruzi infection. <br />    It proposed proteases L. mexicana cleave NF-kB          Interestingly, NF-kB P65 covered surface WT amastigotes <br /> to facilitate immune evasion [35]. We assayed NF-kB               early 30 min post-infection (Figure 4A&#226;&#8364;&#8220;B). Similar results <br /> activation cells recently (#60 min) infected cruzain deficient        observed BESM cells thioglycolate elicited peritoneal <br /> parasites. We compared macrophage activation signaling path-                mouse macrophages (data shown). In contrast, intense NF-kB <br /> ways [36&#226;&#8364;&#8220;39] consequence early infection WT versus             P65 <span id='am-5' about='rdfs:label' typeof='owl:Thing'>label</span> indicative cell activation localized nucleus of <br /> cruzain-deficient T. cruzi. The infection cell population T.        macrophages infected cruzain-deficient T. cruzi (Figure 4C&#226;&#8364;&#8220; <br /> cruzi follows binomial distribution, cells heavily          D) (yellow fluorescence), NF-kB P65 seen bound to <br /> infected cells remain non-infected. Moreover, infection          parasites 60 min. Activation occurred macro- <br /> with high ratio parasites cell results premature rupture        phage controls infected WT T. cruzi presence 10 mM <br /> of heavily infected macrophages. To prevent premature release           K11777 (data shown). <br /> of intracellular parasites secondarily activate macro- <br /> phages population, used low infection ratio 0.5         Colocalization NF-kB cruzain <br /> parasites cell.                                                            Colocalization NF-kB P65 (green fluorescence) cruzain <br />    To detect macrophage activation, performed WB targeting               (red fluorescence) cell surface intracellular parasites <br /> an NF-kB family member specific inhibitor [40&#226;&#8364;&#8220;45].                  occurred macrophages infected WT T. cruzi during <br />  <br />  <br />  <br />  <br /> Figure 1. An active site affinity tag identifies processed active proteases wild type cruzain deficient T. cruzi. Iodinated DCGO4 <br /> (0.1, 1, 10, and-50 mM) reacted epimastigote extracts (105 epimastigotes/lane). Processed, active cruzain (47.5 kD) identified the <br /> major protease wild type T. cruzi. Higher molecular species identified unprocessed cruzain MALDI active protease observed in <br /> cruzain-deficient parasites 50 mM DCG04. <br /> doi:10.1371/journal.ppat.1002139.g001 <br />  <br />  <br />        PLoS Pathogens | www.plospathogens.org                           4                     September 2011 | Volume 7 | Issue 9 | e1002139 <br />                                                                                                             T. cruzi Protease Mediates Immune Evasion <br />  <br />  <br />  <br />  <br /> Figure 2. IEM confirms lack surface-associated cruzain. A cruzain-specific gold-labeled secondary antibody identified cruzain cell <br /> surface intracellular wild type cruzain-deficient T. cruzi amastigotes. A 3-fold (p,0.1) reduction gold-labeled Ab detection cruzain was <br /> present cell surface flagellar pocket cruzain-deficient CA-I/KR (B) versus wild type amastigotes (A) (45,000X). Results representative <br /> of independent experiments. N, nucleus; K, kinetoplast; FP, flagellar pocket; C, cytoplasm BESM cell. <br /> doi:10.1371/journal.ppat.1002139.g002 <br />  <br />  <br />  <br />  <br /> Figure 3. Cruzain-deficient (KR) WT parasites activate NF-kB. Uninfected controls mouse macrophages (MW) infected WT <br /> or KR T. cruzi infected # 1 min (lanes 1, 2), 30 minutes (lanes 3&#226;&#8364;&#8220;7) 60 minutes (lanes 8&#226;&#8364;&#8220;11). Cell extracts western blotted with: <br /> A, anti-NF-kB P65 Ab; B, anti ,P-ikB; C, anti-actin Ab. MW infected follows: lane #1, WT; lane #2, KR; lane #3, uninfected MW; lane #4, WT; <br /> lane #5, KR; lane #6, KR 10 mM K11777; lane #7, KR cultured K777 2 months; lane #8, WT; lane #9, KR; lane #10, KR 10 mM <br /> K11777; lane #11, KR cultured K11777 2 months. Results representative independent experiments using different methods. <br /> Controls (D) MW treated K11777 and/or LPS. <br /> doi:10.1371/journal.ppat.1002139.g003 <br />  <br />  <br />        PLoS Pathogens | www.plospathogens.org                              5                      September 2011 | Volume 7 | Issue 9 | e1002139 <br />                                                                                                         T. cruzi Protease Mediates Immune Evasion <br />  <br />  <br />  <br />  <br /> Figure 4. NF-kB P65 localizes cell surface wild type parasites. Localization NF-kB P65 (green fluorescence) investigated in <br /> mouse macrophages. Parasite host cell DNA labeled PI (red). Non-infected macrophages showed evenly scattered distribution of <br /> cytoplasmic NF-kB P65 (E). Intracellular WT- T. cruzi appeared coated macrophage NF-kB P65 (A, B). In contrast, abundant cytoplasmic (green <br /> fluorescence) nuclear (yellow fluorescence) NF-kB P65 occurred macrophages infected cruzain deficient T. cruzi (C&#226;&#8364;&#8220;D). Macrophages were <br /> infected 30 min (A, C), 60 min (B, D). Results representative independent experiments. <br /> doi:10.1371/journal.ppat.1002139.g004 <br />  <br />  <br />  <br />        PLoS Pathogens | www.plospathogens.org                           6                     September 2011 | Volume 7 | Issue 9 | e1002139 <br />                                                                                                          T. cruzi Protease Mediates Immune Evasion <br />  <br />  <br />  <br />  <br /> Figure 5. Colocalization cruzain NF-kB P65. A&#226;&#8364;&#8220;C. Representative examples colocalization labeled cruzain (A) (red fluorescence) and <br /> NF-kB P65 (B) (green fluorescence) flagellar pocket region and/or cell surface interiorized transforming parasites (C, merge). D. Lack of <br /> colocalization accumulated cruzain (red fluorescence) NF-kB P65 (green) macrophage infected WT T. cruzi treated with <br /> 10 mM K11777 induces accumulation unprocessed zymogen Golgi compartment (arrow) (22). <br /> doi:10.1371/journal.ppat.1002139.g005 <br />  <br /> trypomastigote amastigote transformation (Figure 5A&#226;&#8364;&#8220;C).                    microscopy followed fluorescence quantification Improvi- <br /> Intracellular WT T. cruzi treated trypanocidal inhibitor             sion software. Macrophages infected WT T. cruzi, and <br /> K11777 30 min showed marked cruzain accumulation                          subsequently activated LPS followed BFA treatment, <br /> presumably parasitic Golgi compartment [24]                     showed negligible cytoplasmic IL12 (Figure 8A). A significant <br /> recruitment NF-kB P65 parasite surface (Figure 5D,                  increase (P,0.1) IL12 accumulation occurred macrophages <br /> arrow).                                                                       infected wild type T. cruzi treated inhibitor <br />                                                                               K11777 prevents cruzain activity (Figure 8B). Similarly, <br /> Proteolysis human rNF-kB cruzain                                        activation significant IL12 accumulation occurred macro- <br />    Human rNF-kB P65 proteolytically cleaved major                phages infected cruzain-deficient T. cruzi (Figure 8C). <br /> fragments native cruzain expressed WT (Figure 6) by <br /> proteases expressed cruzain-deficient T. cruzi. Similarly,                 L- arginase assays <br /> recombinant cruzain degraded human r-P65 equimolar                            Other investigators reported increased L-arginase activity <br /> concentrations experimental conditions used                 induced cruzain treatment cells [7]. Only WT parasites <br /> in presence 10 mM K11777.                                              induced 2-5 fold higher L-arginase activity host macrophages <br />                                                                               cruzain-deficient parasites failed increase enzymatic <br /> T. cruzi development macrophages                                           activity (P,0.01). Representative values 3 indepen- <br />    To understand effect macrophage activation [37,42]               dent experiments 3.1360.02 mg urea/ml macrophages <br /> T. cruzi intracellular survival development, performed                 infected WT parasites, 1.5660.02 mg urea/ml macro- <br /> quantitative vitro assays [26]. T. cruzi divided normally control       phages infected cruzain-deficient parasites, 1.560.01 mg <br /> macrophages mean number parasites cell (P/cell)                urea/ml uninfected macrophages. <br /> increased ,0.5 to 2.8 48 h (Figure 7) [23]. Activation <br /> of macrophages purified LPS 1h prior concomitantly                 Discussion <br /> with infection resulted parasite death. T. cruzi developed in <br /> macrophages treated LPS 1h post-infection; lower mean                   A complex dynamic scenario host cell-parasite <br /> P/cell probably results death parasites trapped          interactions apparent pathogens use different <br /> the parasitophorus vacuole activation occurred. Thus                     mechanisms subvert host-cell signaling pathways modulate <br /> macrophage unresponsiveness early infection (,60 min)                   kinetics intracellular development. Several reports <br /> crucial parasite survival intracellular development.                  T. cruzi modulates signaling pathways mammalian <br />                                                                               cells [15,43,44]. Some authors propose activation NF-kB <br /> IL12 expression                                                               proteins modulate tissue specificity, muscle cells that <br />   To confirm macrophage unresponsiveness infection WT                 preferentially harbor T. cruzi activated [37] while <br /> T. cruzi infection, investigated IL12 expression confocal          detect muscle endothelial cell activation post-infection <br />  <br />  <br />        PLoS Pathogens | www.plospathogens.org                             7                    September 2011 | Volume 7 | Issue 9 | e1002139 <br />                                                                                                                T. cruzi Protease Mediates Immune Evasion <br />  <br />  <br />  <br />  <br /> Figure 6. Proteolytic cleavage r-human NF-kB P65 wild type- r-cruzain proteases expressed cruzain- <br /> deficient T. cruzi. Recombinant human NF-kB P65 treated cruzain parasite extracts. Lane 1, untreated control; lane 2, r-cruzain <br /> (1:1 molar ratio); lanes 3&#226;&#8364;&#8220;4: dilutions 1:10 1:100 r-cruzain, respectively; lane 5, r-cruzain (1:1 molar ratio) 10 mM K11777; lane 6, WT cruzain; <br /> lane 7, proteases cruzain-deficient T. cruzi. Results representative independent experiments. <br /> doi:10.1371/journal.ppat.1002139.g006 <br />  <br /> [45,46]. Our investigate role protease                intensity activating signal. NF-kB complexes normally <br /> cruzain early infection (,60 min) macrophages T.                    inactive cytoplasm activation enter nucleus <br /> cruzi, particular nuclear factor NF-kB P65, using              modulate gene expression. Membrane receptors (e.g. TRL) and <br /> inhibitor K11777 phenotypic cruzain knockouts [22].                          signaling regulators involved [38&#226;&#8364;&#8220;42,43&#226;&#8364;&#8220;52]. <br />    A major role NF-kB family regulation aspects                 To compare infection WT versus cruzain-deficient T. cruzi, <br /> the innate adaptive immune responses. NF-kB members                          performed WB NF-kB P65 ,P ikB (Figure 3) [39,47] <br /> control transcription genes encoding cytokines                        showed unresponsiveness macrophages infected WT <br /> antimicrobial molecules, genes regulating cell differenti-            parasites. Confocal studies showed WT parasites rapidly <br /> ation, survival, proliferation apoptosis [38]. The complex                   sequestered NF-kB P65 cell surface (Figure 4, A&#226;&#8364;&#8220;B). <br /> response depends cell type nature, duration                Similar events occurred early infection peritoneal mouse <br />  <br />  <br />  <br />  <br /> Figure 7. Macrophage activation prevents T. cruzi intracellular development. Mouse macrophages infected wild type T. cruzi and <br /> LPS added indicated. Mean parasites/cell determined 1 h 48 h post-infection. Parasite death occurred LPS added prior <br /> to concomitantly T. cruzi trypomastigotes. Results representative independent experiments (n = 3 treatment). <br /> doi:10.1371/journal.ppat.1002139.g007 <br />  <br />  <br />        PLoS Pathogens | www.plospathogens.org                                8                      September 2011 | Volume 7 | Issue 9 | e1002139 <br />                                                                                                                     T. cruzi Protease Mediates Immune Evasion <br />  <br />  <br />  <br />  <br /> Figure 8. IL-12 expression. No significant IL12 expression detected macrophages infected wild type T. cruzi cells treated with <br /> 10 mM K11777 significantly higher cytoplasmic IL12 levels. Increased IL12 expression occurred macrophages infected cruzain- <br /> deficient T. cruzi. Results representative independent experiments. A. Wild type-infected control. B. Macrophage infected wild type T. <br /> cruzi treated 10 mM K11777. C. Macrophage infected cruzain-deficient T. cruzi. <br /> doi:10.1371/journal.ppat.1002139.g008 <br />  <br />  <br />  <br /> macrophages BESM cells (data shown). Cruzain localized                         case T. cruzi, TLR2 TLR9 receptors mediate cellular <br /> to cell surface WT intracellular amastigotes (Figure 2) [53]                    activation [43,59,66,72&#226;&#8364;&#8220;73]. <br /> and colocalized NF-kB P65 (Figure 5). Treatment                                 Our results macrophages infected WT T. cruzi <br /> K11777 caused accumulation unprocessed inactive                                 remained unresponsive early infection, support the <br /> protease Golgi [24] abrogated NF-kB P65 sequestration                       hypothesis intracellular pathogens uniquely protected <span id='am-4' about='protege:FROM' typeof='owl:Thing'>from</span> <br /> by parasite (Figure 5D). Degradation NF-kB P65 noted                        macrophage activation [38]. Confirming results, expression <br /> 60 min infection wild-type T. cruzi (Figure 3) native                   profiling bone marrow macrophages infected T. cruzi <br /> cruzain degraded recombinant nuclear factor (Figure 6). More-                          revealed transcriptional changes 12 hours. <br /> over, inhibition IL12 confirmed macrophage unresponsiveness                         At 24 hours post infection, macrophages fibroblasts <br /> in early WT T. cruzi infection (Figure 8A).                                            express interferon-regulated genes [62,74,75]. The L. mexicana <br />    In contrast, macrophages infected cruzain-deficient T. cruzi                   cruzain homologue, &#226;&#8364;&#732;&#226;&#8364;&#732;cpb&#226;&#8364;&#8482;&#226;&#8364;&#8482;, likewise degrades NF-kB P65, IkBa, <br /> became rapidly activated NF-kB P65 (Figure 3, KR)                              IkBbpreventing macrophage activation [35]. Similar strategies <br /> intense nuclear localization P65 occurred shortly infection                   suppress immune responses coccidian <br /> (Figure 4C&#226;&#8364;&#8220;D) highlighting role cruzain modulation                     parasite Theileria [76], poliovirus picornavirus as <br /> host cell signaling pathways. As anticipated, infection cruzain-                  viral proteases cleave NF-kB P65 generating inactive products [77]. <br /> deficient parasites induced IL12 accumulation (Figure 8C).                             We hypothesize cruzain plays key role degrading NF- <br />    Preventing macrophage activation crucial successful                        kB P65 hindering activation innate phagocytes recruited to <br /> infection. Indeed, wild type T. cruzi killed macrophages                     bite site [5]. Macrophage unresponsiveness favor parasite <br /> were activated LPS prior infection (Figure 7),                       survival early infection delay onset immune <br /> presumably parasites contained parasito-                    response. A successful macrophage infection results the <br /> phorus vacuole [54&#226;&#8364;&#8220;57] susceptible cidal macrophage                         production hundreds infectious T. cruzi. For example single <br /> products. Other macrophage metabolic pathways modu-                          CA-I/72 parasite originates ,130 infectious trypomastigotes just <br /> lated T. cruzi. Infection WT cruzain-deficient T. cruzi                4.5 days [23]. Once host immune response triggered [65&#226;&#8364;&#8220; <br /> significantly increased L-arginase activity [6,7]. A similar phenome-                  67], parasite development restricted permissive tissues <br /> non occurs Leishmania infection [58]. We observed down-                    muscle cells [37,71]. Thus cruzain function the <br /> modulation macrosialin, murine analog human CD68,                         early events macrophage infection favoring immune evasion by <br /> cells infected WT T. cruzi (not shown). Further studies                       T. cruzi. <br /> identify host cell molecules modulated T. cruzi [59&#226;&#8364;&#8220;63]. <br />    Experimental clinical evidence shows correlation                      Acknowledgments <br /> the severity Chagas&#226;&#8364;&#8482; disease persistence T. cruzi                        In memory James A. Dvorak, NIH. We thank A. Ma R. Tavares for <br /> within tissues [64&#226;&#8364;&#8220;65]. NF-kB complexes important                          helpful discussion, C. Franklin technical assistance. K.F. <br /> development function innate adaptive immune                            Medzihradszky performed peptide analyses P. Loke, FACS analysis <br /> responses triggered pathogens [38,51]. Metabolic pathways                        (data shown). <br /> the innate immune induced early infection have <br /> important consequences evolution disease                         Author Contributions <br /> play role control T. cruzi replication, tissue distribution                Conceived designed experiments: PSD JCE. Performed the <br /> and degree parasitism. As infection progresses, adaptive                         experiments: PSD YMZ IH JCE. Analyzed data: PSD JCE JHM DCG. <br /> immune response develops production high levels                             Contributed reagents/materials/analysis tools: DCG. Wrote paper: <br /> inflammatory cytokines, IFNc NO radicals [38,59,66&#226;&#8364;&#8220;71]. In                         PSD. <br />  <br />  <br /> References <br />  1. Urbina JA (2010) Specific chemotherapy Chagas disease: relevance, current       2. Buckner FS, Navabi N (2010) Advances Chagas disease drug development: <br />     limitations new approaches. Acta Trop 115: 55&#226;&#8364;&#8220;68.                                 2009-2010. Curr Opinion Infect Dis 23: 609&#226;&#8364;&#8220;616. <br />  <br />  <br />  <br />        PLoS Pathogens | www.plospathogens.org                                      9                      September 2011 | Volume 7 | Issue 9 | e1002139 <br />                                                                                                                                    T. cruzi Protease Mediates Immune Evasion <br />  <br />  <br />  3. McKerrow JH, Doyle PS, Engel JC, Podust LM, Robertson SA, et al. (2009)                       31. Hitotsumatsu O, Ahmad RE, Tavares RM, Wang M, Philpott D, et al. (2008) <br />     Two approaches discovering developing new drugs Chagas disease.                        The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization <br />     Mem Inst Oswaldo Cruz 104: 263&#226;&#8364;&#8220;269.                                                               domain containing 2-triggered signals. Immunity 28: 381&#226;&#8364;&#8220;390. <br />  4. Chagas C In:, Coletanea Trabalhos Cientificos 1909-1913. Editora                           32. Tavares RM, Turer EE, Liu CL, Advincula R, Scapini P, et al. (2010) The <br />     Universidade Brasilia. pp 237&#226;&#8364;&#8220;335.                                                             Ubiquitin Modifying Enzyme A20 Restricts B <span id='am-86' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-87' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-91' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-95' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-97' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-98' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-99' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-101' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-109' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-112' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-116' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-125' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-132' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-135' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-136' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-141' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-142' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-152' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-154' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-160' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-161' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-162' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span>Cell Survival</span> Prevents <br />  5. Schuster JP, Schaub GA (2000) Trypanosoma cruzi: skin-penetration kinetics                     Autoimmunity. Immunity 33: 181&#226;&#8364;&#8220;191. <br />     vector derived metacyclic trypomastigotes. Int J Parasitol 30: 1475&#226;&#8364;&#8220;1479.                     33. Quinones M, Ahuja SK, Melby PC, Pate L, Reddick RL, et al. (2000) Preformed <br />  6. Giordanengo L, Guinazu N, Stempin C, Fretes R, Cerban FM, et al. (2002)                           membrane-associated stores interleukin (IL)-12 previously unrecognized <br />     Cruzipain, major Trypanosoma cruzi antigen, conditions host immune                          source bioactive IL-12 mobilized minutes contact an <br />     response favor parasite. Eur J Immunol 32: 1003&#226;&#8364;&#8220;1011.                                       intracellular parasite. Exp Med 192: 507&#226;&#8364;&#8220;515. <br />  7. Stempin CS, Tanos TB, Coso OA, Cerba&#194;&#180;n FM (2003) Arginase induction                           34. Corraliza IM, Campo ML, Soler G, Modollel M (1994) Determination of <br />     promotes Trypanosoma cruzi intracellular replication Cruzipain-treated J774                    arginase activity macrophages: micromethod. J Immunol Methods 174: <br />     cells activation multiple signaling pathways. Eur J Immunol 34:                    231&#226;&#8364;&#8220;235. <br />     200&#226;&#8364;&#8220;209.                                                                                      35. Cameron P, McGachy A, Anderson M, Paul A, Coombs GH, et al. (2004) <br />  8. Tomas AM, Kelly JM (1994) Transformation approach functional                             Inhibition lipopolysaccharide-induced macrophage IL-12 production by <br />     analysis major cysteine protease Trypanosoma cruzi. Biochem Soc Trans                   Leishmania mexicana amastigotes: role cysteine peptidases NF- <br />     22: 90S.                                                                                          kappaB signaling pathway. J Immunol 173: 3297&#226;&#8364;&#8220;3304. <br />  9. Tomas AM, Kelly JM (1996) Stage-regulated expression cruzipain, major                  36. Ghosh S (1999) Regulation inducible gene expression transcription <br />     cysteine protease Trypanosoma cruzi independent level RNA. Mol                    factor NF-kB. Immunol Res 19: 183&#226;&#8364;&#8220;189. <br />     Biochem Parasitol 76: 91&#226;&#8364;&#8220;103. <br />                                                                                                   37. Hall BS, Tam W, Sen R, Pereira ME (2000) Cell-specific activator nuclear <br /> 10. Tomas AM, Miles MA, Kelly JM (1997) Overexpression cruzipain, major <br />                                                                                                       factor kappa B parasite Trypanosoma cruzi promotes resistance to <br />     cysteine proteinase Trypanosoma cruzi, associated enhanced metacyclo- <br />                                                                                                       intracellular infection. Mol Biol Cell 11: 153&#226;&#8364;&#8220;160. <br />     genesis. Eur J Biochem 244: 596&#226;&#8364;&#8220;603. <br />                                                                                                   38. Hayden MS, West AP, Ghosh S (2006) NF-kB immune response. <br /> 11. Yong V, Schmitz V, Vannier-Santos MA, Lima AP, Lalmanach G, et al. <br />                                                                                                       Oncogene 25: 6758&#226;&#8364;&#8220;6780. <br />     (2000) Altered expression cruzipain cathepsin B-like target a <br />     Trypanosoma cruzi cell line displaying resistance synthetic inhibitors cysteine-        39. Chen Y, Vallee S, Wu J, Vu D, Sondek J, et al. (2004) Inhibition NF-kB <br />     proteinases. Mol Biochem Parasitol 109: 47&#226;&#8364;&#8220;59.                                                    activity IkBb association kB-ras. Mol Cell Biol 24: 3048&#226;&#8364;&#8220;3056. <br /> 12. Lima A P A, dos Reis CGF, Serveau C, Lalmanach G, Juliano L, et al. (2001)                    40. DiDonato JA, Mercurio F, Karin M (1995) Phosphorylation ikBa&#194;&#180; precedes <br />     Cysteine protease isoforms Trypanosoma cruzi, cruzipain 2 cruzain,                       sufficient dissociation NF-kB. Mol Cell Biol 15: <br />     present different substrate preference susceptibility inhibitors. Mol                      1302&#226;&#8364;&#8220;1311. <br />     Biochem Parasitol 114: 41&#226;&#8364;&#8220;52.                                                                 41. Marienfeld RF, Palkowitsch L, Ghosh S (2006) Dimerization ikB kinase- <br /> 13. Lima AP, Almeida PC, Tersariol LL, Schmitz V, Schmaier AH, et al. (2002)                          binding domain NEMO required tumor necrosis factor alpha-induced <br />     Heparan sulfate modulates kinin release Trypanosoma cruzi activity                 NF-kB activity. Mol Cell Biol 26: 9209&#226;&#8364;&#8220;9219. <br />     cruzipain. J Biol Chem 277: 5875&#226;&#8364;&#8220;5881.                                                     42. De Plaen I, Han XB, Liu X, Hsueh W, Ghosh S, et al. (2006) <br /> 14. Scharfstein J, Schmitz V, Morandi V, Capella MM, Lima AP, et al. (2000) Host                      Lipopolysaccharide induces CXCL2/macrophage inflammatory protein-2 gene <br />     cell invasion Trypanosoma cruzi potentiated activation bradykinin B(2)                expression enterocytes NF-kB activation: independence endogenous <br />     receptors. J Exp Med 192: 1289&#226;&#8364;&#8220;1300.                                                              TNF-a platelet activation factor. Immunology 118: 153&#226;&#8364;&#8220;163. <br /> 15. Aoki MP, Cano RC, Pellegrini AV, Tanos T, Guinazu NL, et al. (2006)                           43. Petersen CA, Krumholz KA, Burleigh BA (2005) Toll-like receptor 2 modulates <br />     Different signaling pathways involved cardiomyocyte survival induced                    IL-1B dependent cardiomyocyte hypertrophy triggered Trypanosoma cruzi. Inf <br />     Trypanosoma cruzi glycoprotein. Microbes Infect 8: 1723&#226;&#8364;&#8220;1731.                                   Immun 73: 6974&#226;&#8364;&#8220;6980. <br /> 16. Eakin AE, Mills AA, Harth G, McKerrow JH, Craik CS (1992) The sequence,                       44. Petersen CA, Krimholz KA, Carmen J, Sinai AP, Burleigh BA (2006) <br />     organization, expression major cysteine protease (cruzain)                        Trypanosoma cruzi infection nuclear factor kappa B activation prevent <br />     Trypanosoma cruzi. J Biol Chem 267: 7411&#226;&#8364;&#8220;7420.                                                    apoptosis cardiac cells. Inf Imm 74: 1580&#226;&#8364;&#8220;1587. <br /> 17. Cazzulo JJ (1999) Cruzipain, major cysteine proteinase Trypanosoma cruzi:                  45. Ba X, Shivali Gupta S, Davidson M, Garg NJ (2010) Trypanosoma cruzi Induces <br />     sequence genomic organization codifying genes. Medicina (B Aires)                      Reactive Oxygen Species-PARP-1-RelA Pathway Up-regulation of <br />     59: 7&#226;&#8364;&#8220;10.                                                                                         Cytokine Expression Cardiomyocytes. J Biol Chem 285: 11596&#226;&#8364;&#8220;11606. <br /> 18. Engel JC, Doyle PS, Hsieh I, McKerrow JH (1998) Cysteine protease inhibitors                  46. Huang H, Calderon TM, Berman JW, Braunstein VL, Weiss LM, et al. (1999) <br />     cure experimental Trypanosoma cruzi infection. J Exp Med 188: 725&#226;&#8364;&#8220;734.                         Infection Endothelial Cells Trypanosoma cruzi Activates NF-kB and <br /> 19. Duschak VG, Ciaccio M, Nassert JR, Basombrio MA (2001) Enzymatic activity,                        Induces Vascular Adhesion Molecule Expression. Infect Immun. 67: 5434&#226;&#8364;&#8220;5440. <br />     protein expression, gene sequence cruzipain virulent attenuated                 47. Wu C, Gosh S (2003) Differential phosphorylation signal-responsive <br />     Trypanosoma cruzi strains. J Parasitol 87: 1016&#226;&#8364;&#8220;1022.                                             domain ikBa ikBb IkB kinases. J Biol Chem 34: 31980&#226;&#8364;&#8220;31987. <br /> 20. Duschak VG, Riarte A, Segura EL, Laucella SA (2001) Humoral immune                            48. Baeuerle PA, Baltimore D (1996) NF-kB years after. Cell 87: 113&#226;&#8364;&#8220;120. <br />     response cruzipain cardiac dysfunction chronic Chagas&#226;&#8364;&#8482; disease.                     49. Israel A, Kroemer G (2006) NF-kB life/death decisions: introduction. <br />     Immunol Letters 78: 135&#226;&#8364;&#8220;142.                                                                      Cell Death Differ 13: 685&#226;&#8364;&#8220;686. <br /> 21. Paiva CN, Souto-Padron T, Costa DA, Gattass CR (1998) High expression                    50. Perkins ND, Gilmore TD (2006) Good cop, bad cop: different faces NF- <br />     functional cruzipain non-infective non-pathogenic Trypanosoma cruzi                      kB. Cell Death Differ 13: 759&#226;&#8364;&#8220;772. <br />     clone. Parasitology 117: 483&#226;&#8364;&#8220;940.                                                             51. Liou HC, Hsia CY (2003) Distinctions c-Rel NF-kB proteins <br /> 22. Engel JC, Torres Garcia C, Hsieh I, Doyle PS, McKerrow JH (2000)                                  immunity disease. Bioassays 25: 767&#226;&#8364;&#8220;780. <br />     Upregulation secretory pathway cysteine protease inhibitor-resistant                52. Nelson DE, Ihekwaba AEC, Elliot M, Johnson JR, Gibney CA, et al. (2004) <br />     Trypanosoma cruzi. J Cell Science 113: 1345&#226;&#8364;&#8220;1354. <br />                                                                                                       Oscillations NF-kB signaling control dynamics gene expression. Science <br /> 23. Engel JC, Doyle PS, Dvorak JA (1985) Trypanosoma cruzi: Biological <br />                                                                                                       306: 704&#226;&#8364;&#8220;708. <br />     characterization clones derived chronic chagasic patients. II. <br />                                                                                                   53. Nascimento AE, Souza W (1996) High resolution localization cruzipain <br />     Quantitative analysis intracellular cycle. J Protozool 32: 80&#226;&#8364;&#8220;83. <br />                                                                                                       Ssp4 Trypanosoma cruzi replica staining label fracture. Biol Cell 86: <br /> 24. Engel JC, Doyle PS, Palmer J, Hsieh I, Bainton DF, et al. (1998) Cysteine <br />                                                                                                       53&#226;&#8364;&#8220;58. <br />     protease inhibitors alter Golgi complex ultrastructure function in <br />     Trypanosoma cruzi. J Cell Sci 111: 597&#226;&#8364;&#8220;606.                                                   54. Burleigh BA, Andrews NW (1995) The mechanisms Trypanosoma cruzi invasion <br /> 25. Engel JC, Cazzulo BMF, Stoppani OAM, Canatta JJB, Cazzulo JJ (1987)                            mammalian cells. Ann Rev Microbiol 49: 175&#226;&#8364;&#8220;200. <br />     Aerobic glucose fermentation Trypanosoma cruzi axenic culture amastigote-like              55. Burleigh BA (2005) Host cell signaling Trypanosoma cruzi invasion: all <br />     forms growth differentiation epimastigotes. Mol Bioch Parasitol                     roads lead lysosomes? Sci STKE 293: 36&#226;&#8364;&#8220;43. <br />     26: 1&#226;&#8364;&#8220;10.                                                                                     56. Ley V, Andrews NW, Robbins ES, Nussenzweig V (1998) Amastigotes of <br /> 26. Doyle PS, Dvorak JA, Engel JC (1984) Trypanosoma cruzi: Quantification                        Trypanosoma cruzi sustain infective cycle mammalian cells. J Exp Med 168: <br />     analysis infectivity cloned stocks. J Protozool 31: 280&#226;&#8364;&#8220;283.                            649&#226;&#8364;&#8220;659. <br /> 27. Bogyo M, Verhelst S, Bellingard-Dubouchaud V, Toba S, Greenbaum DC                            57. Kima PE, Burleigh BA, Andrews NW (2000) Surface-targeted lysosomal <br />     (2000) Selective targeting lysosomal cysteine proteases radiolabeled                      membrane glyocoprotein-1 (Lamp-1) enhances lysosome exocytosis cell <br />     electrophilic substrate analogs. Chem Biol 7: 27&#226;&#8364;&#8220;38.                                              invasion Trypanosoma cruzi. Cell Microbiol 2: 477&#226;&#8364;&#8220;486. <br /> 28. Greenbaum DC, Medzihradszky KF, Burlingame A, Bogyo M (2000) Epoxide                          58. Gaur U, Roberts SC, Dalvi RP, Corraliza I, Ullman B, et al. (2007) An Effect of <br />     electrophiles activity-dependent cysteine protease profiling discovery                     Parasite-Encoded Arginase Outcome Murine Cutaneous Leishman- <br />     tools. Chem Biol 7: 569&#226;&#8364;&#8220;581.                                                                      iasis. J Immunol 179: 8446&#226;&#8364;&#8220;8453. <br /> 29. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ (2000) Cutting edge:                           59. Campos MA, Closel M, Valente EP, Cardoso JE, Akira S, et al. (2004) Impaired <br />     repurification lipopolysaccharide eliminates signaling human                      production proinflammatory cytokines host resistance acute infection <br />     murine toll-like receptor 2. J Immunol 165: 618&#226;&#8364;&#8220;622.                                          Trypanosoma cruzi mice lacking functional myeloid differentiation factor <br /> 30. Turer EE, Tavares RM, Mortier E, Hitotsumatsu O, Advincula R, et al. (2008)                       88. J Immunol 172: 1711&#226;&#8364;&#8220;1718. <br />     Homeostatic MyD88-dependent signals cause lethal inflammation                          60. Gordon S (2003) Alternative activation macrophages. Nature Rev Immunol 3: <br />     absence A20. J Exp Med 205: 451&#226;&#8364;&#8220;464.                                                           23&#226;&#8364;&#8220;35. <br />  <br />  <br />  <br />          PLoS Pathogens | www.plospathogens.org                                              10                         September 2011 | Volume 7 | Issue 9 | e1002139 <br />                                                                                                                               T. cruzi Protease Mediates Immune Evasion <br />  <br />  <br /> 61. Noe&#194;&#168;l W, Raes G, Ghassabeh GH, De Baetselier P, Beschin A (2004)                         70. Bergeron M, Olivier M (2006) Trypanosoma cruzi-Mediated IFN-Inducible Nitric <br />     Alternatively activated macrophages parasite infections. Tr Parasitol                 Oxide Output Macrophages Is Regulated iNOS mRNA Stability. <br />     20: 126&#226;&#8364;&#8220;133.                                                                                 J Immunol 177: 6271&#226;&#8364;&#8220;80. <br /> 62. Zhang S, Kim CC, Batra S, McKerrow JH, Loke P (2010) Delineation diverse              71. Huang H, Petkova SB, Cohen AW, Bouzahzah B, Chan J, et al. (2003) <br />     macrophage activation programs response intracellular parasites                    Activation transcription factors AP-1 NF-kB murine chagasic <br />     cytokines. PLoS Negl Trop Dis 4: e648.                          <br /> </body></html>